Home/Filings/4/0001746473-24-000063
4//SEC Filing

Cummings Keith Lamont 4

Accession 0001746473-24-000063

CIK 0001746473other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 6:02 AM ET

Size

7.1 KB

Accession

0001746473-24-000063

Insider Transaction Report

Form 4
Period: 2024-05-02
Cummings Keith Lamont
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-0221,00076,047 total
    Exercise: $2.08Exp: 2029-01-24Common Stock (21,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-02$2.08/sh+21,000$43,680271,713 total
Footnotes (2)
  • [F1]Includes 858 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
  • [F2]25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001809204

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 6:02 AM ET
Size
7.1 KB